Performances of different classification criteria for systemic lupus erythematosus in a single-center cohort from Turkey.
- Published in:
- Lupus, 2022, v. 31, n. 12, p. 1536, doi. 10.1177/09612033221126866
- By:
- Publication type:
- Article
Works matching IS 09612033 AND DT 2022 AND VI 31 AND IP 12
Results: 16
1
2
ASIA syndrome with severe lupus – A case report.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
3
Premature ovarian failure in juvenile systemic lupus erythematosus patient: A rare presentation.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
4
Korean LupusPRO: Cross-Cultural validation study for systemic lupus erythematosus.
- Published in:
- Lupus, 2022, v. 31, n. 12, p. 1498, doi. 10.1177/09612033221122984
- By:
- Publication type:
- Article
5
Lupus nephritis: A focus on the United Arab Emirates and the potential role of genetics.
- Published in:
- Lupus, 2022, v. 31, n. 12, p. 1415, doi. 10.1177/09612033221122982
- By:
- Publication type:
- Article
6
Late-onset cutaneous lupus erythematosus patients have distinctive clinical features and demographics versus early-onset patients.
- Published in:
- Lupus, 2022, v. 31, n. 12, p. 1523, doi. 10.1177/09612033221122254
- By:
- Publication type:
- Article
7
The association of psychosocial stressors and psychiatric disorders with fatigue in systemic lupus erythematosus patients.
- Published in:
- Lupus, 2022, v. 31, n. 12, p. 1491, doi. 10.1177/09612033221122225
- By:
- Publication type:
- Article
8
Serologic phenotypes distinguish systemic lupus erythematosus patients developing interstitial lung disease and/or myositis.
- Published in:
- Lupus, 2022, v. 31, n. 12, p. 1477, doi. 10.1177/09612033221122158
- By:
- Publication type:
- Article
9
Multitarget therapy versus monotherapy as induction treatment for lupus nephritis: A meta-analysis of randomized controlled trials.
- Published in:
- Lupus, 2022, v. 31, n. 12, p. 1468, doi. 10.1177/09612033221122148
- By:
- Publication type:
- Article
10
The use of fondaparinux and rituximab for recurrent thrombotic events in antiphospholipid syndrome.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
11
Elevated apoptosis and abnormal apoptosis signaling of regulatory T cells in patients with systemic lupus erythematosus.
- Published in:
- Lupus, 2022, v. 31, n. 12, p. 1441, doi. 10.1177/09612033221119455
- By:
- Publication type:
- Article
12
Efficacy and safety of belimumab in systemic lupus erythematosus patients with severe lupus nephritis requiring renal replacement therapy.
- Published in:
- Lupus, 2022, v. 31, n. 12, p. 1456, doi. 10.1177/09612033221119123
- By:
- Publication type:
- Article
13
Electronic health record data use in the assessment of quality indicators for glucocorticoid osteoporosis screening in systemic lupus erythematosus.
- Published in:
- Lupus, 2022, v. 31, n. 12, p. 1516, doi. 10.1177/09612033221116726
- By:
- Publication type:
- Article
14
Adherence to medication by adolescents and young adults with childhood-onset systemic lupus erythematosus.
- Published in:
- Lupus, 2022, v. 31, n. 12, p. 1508, doi. 10.1177/09612033221115974
- By:
- Publication type:
- Article
15
Importance of temporality and context in relation to life habit restrictions among patients with systemic lupus erythematosus: A psychosocial qualitative study.
- Published in:
- Lupus, 2022, v. 31, n. 12, p. 1423, doi. 10.1177/09612033221115966
- By:
- Publication type:
- Article
16
Temporal trends in hospitalisation for opportunistic infections in lupus patients in Western Australia.
- Published in:
- Lupus, 2022, v. 31, n. 12, p. 1434, doi. 10.1177/09612033221115965
- By:
- Publication type:
- Article